Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

Long-term increases in plasma fibrinogen levels of 1 g/liter are associated with an approximate doubling of risk of major cardiovascular disease outcomes, but causality remains uncertain. To quantify cross-sectional associations of fibrinogen levels with established risk factors and other characteristics, the investigators combined individual data on 154,211 apparently healthy adults from 31 prospective studies conducted between 1967 and 2003, using a linear mixed model that included random effects at the cohort level. Fibrinogen levels increased with age and showed continuous, approximately linear relations with several risk markers and slightly curvilinear associations with log triglycerides, albumin, and tobacco and alcohol consumption. Female sex, Black ethnicity, lower socioeconomic status, and alcohol abstinence were each associated with modestly higher fibrinogen levels. Approximately one third of the variation in fibrinogen levels was explained by cohort, age, and sex. An additional 7% was explained by established risk factors (notably, positive associations with smoking and body mass index and an inverse association with high density lipoprotein cholesterol), and a further 10% was explained by inflammatory markers (notably, a positive association with C-reactive protein). The association with body mass index was twice as strong in women as in men, whereas the association with smoking was much stronger in men. These findings substantially advance understanding of the correlates and possible determinants of fibrinogen levels.

[1]  J. Danesh,et al.  Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. , 2006, International journal of epidemiology.

[2]  M. Ntefidou,et al.  SSC International Collaborative Study to establish the first high fibrinogen plasma reference material for use with different fibrinogen assay techniques , 2006, Journal of thrombosis and haemostasis : JTH.

[3]  S. Humphries,et al.  Commentary: fibrinogen and coronary heart disease--test of causality by 'Mendelian' randomization by Keavney et al. , 2006, International journal of epidemiology.

[4]  Sarah Parish,et al.  Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. , 2006, International journal of epidemiology.

[5]  P. Whincup,et al.  Effects of older age on fibrin D‐dimer, C‐reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years , 2006, Journal of thrombosis and haemostasis : JTH.

[6]  K. Kodama,et al.  Effect of conventional risk factors for excess cardiovascular death in men: NIPPON DATA80. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[7]  G. Kelly Seasonal variations of selected cardiovascular risk factors. , 2005, Alternative medicine review : a journal of clinical therapeutic.

[8]  H Tunstall-Pedoe,et al.  Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. , 2005, JAMA.

[9]  Shah Ebrahim,et al.  Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?: Evidence from a Meta-Analysis of Genetic Association Studies , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  P. Whincup,et al.  Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. , 2005, European heart journal.

[11]  G. Lowe Circulating inflammatory markers and risks of cardiovascular and non‐cardiovascular disease , 2005, Journal of thrombosis and haemostasis : JTH.

[12]  P. Whincup,et al.  The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. , 2005, Atherosclerosis.

[13]  V. Salomaa,et al.  Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study. , 2005, European heart journal.

[14]  G. Lowe,et al.  Plasma fibrinogen , 2004, Annals of clinical biochemistry.

[15]  P. Whincup,et al.  Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease , 2004, Diabetologia.

[16]  G. Lowe,et al.  Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  Alicja R. Rudnicka,et al.  Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[18]  P. Whincup,et al.  The effects of different alcoholic drinks on lipids, insulin and haemostatic and inflammatory markers in older men , 2003, Thrombosis and Haemostasis.

[19]  G. Lip,et al.  Fibrinogen: biochemistry, epidemiology and determinants. , 2003, QJM : monthly journal of the Association of Physicians.

[20]  M. Woodward,et al.  C‐reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease , 2003, British journal of haematology.

[21]  W. Koenig Fibrin(ogen) in cardiovascular disease: an update , 2003, Thrombosis and Haemostasis.

[22]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[23]  P. Whincup,et al.  Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men , 2002, Circulation.

[24]  D. Stirling,et al.  Interleukin 6 and Haemostasis , 2001, British journal of haematology.

[25]  M. D. Maat Effects of Diet, Drugs, and Genes on Plasma Fibrinogen Levels , 2001 .

[26]  M. D. de Maat Effects of diet, drugs, and genes on plasma fibrinogen levels. , 2001, Annals of the New York Academy of Sciences.

[27]  P. Gaffney,et al.  A Collaborative Study to Establish the 2nd International Standard for Fibrinogen, Plasma , 2000, Thrombosis and Haemostasis.

[28]  M. Woodward,et al.  Associations of blood rheology and interleukin‐6 with cardiovascular risk factors and prevalent cardiovascular disease , 1999, British journal of haematology.

[29]  P. Brennan,et al.  Thrombosis prevention trial , 1998 .

[30]  M. Woodward,et al.  EPIDEMIOLOGY OF COAGULATION FACTORS, INHIBITORS AND ACTIVATION MARKERS: THE THIRD GLASGOW MONICA SURVEY I. ILLUSTRATIVE REFERENCE RANGES BY AGE, SEX AND HORMONE USE , 1997, British journal of haematology.

[31]  H. Iso,et al.  Plasma fibrinogen and its correlates in urban Japanese men. , 1996, International journal of epidemiology.

[32]  P. Savage,et al.  Association of Fibrinogen and Coagulation Factors Vll and VIII with Cardiovascular Risk Factors in the Elderly The Cardiovascular Health Study , 1996 .

[33]  A. Folsom Epidemiology of fibrinogen. , 1995, European heart journal.

[34]  A. Folsom,et al.  Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 1993, American journal of epidemiology.

[35]  Donald A. Smith Fibrinogen as a cardiovascular risk factor: a meta-analysis , 1993, ACP Journal Club.

[36]  P. Gaffney,et al.  Collaborative Study of a Proposed International Standard for Plasma Fibrinogen Measurement , 1992, Thrombosis and Haemostasis.

[37]  U. Keil,et al.  Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  A. Folsom,et al.  Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. , 1991, Atherosclerosis.

[39]  H. Tunstall-Pedoe,et al.  Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study. , 1991, Journal of clinical epidemiology.

[40]  L. Wilhelmsen,et al.  Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. , 1990, BMJ.

[41]  A. Folsom,et al.  Hemostatic variables in Japanese and Caucasian men. Plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. , 1989, American journal of epidemiology.

[42]  T. Meade,et al.  EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASE , 1987, The Lancet.

[43]  M. Blombäck,et al.  GENETIC AND CULTURAL INHERITANCE OF PLASMA FIBRINOGEN CONCENTRATION , 1987, The Lancet.

[44]  S. Humphries,et al.  ROLE OF GENETIC VARIATION AT THE FIBRINOGEN LOCUS IN DETERMINATION OF PLASMA FIBRINOGEN CONCENTRATIONS , 1987, The Lancet.

[45]  S. Thompson,et al.  An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group. , 1986, International journal of epidemiology.